Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis

BackgroundAngiotensin II receptor blockers (ARBs) are utilized for the management of hypertension and diabetes. Previous meta-analyses suggested that azilsartan medoxomil (AZL-M) improved blood pressure (BP) reduction, but there were no safety findings or suggestions for patients with hypertension o...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Ling Zhu, Guo-Cui Wei, Qing Xiao, Qian-Lan Chen, Qian Zhao, Xiu-xia Li, Ling-ai Pan, Xuan Xiong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	azilsartan medoxomil hypertension diabetes meta-analysis angiotensin II receptor blockers (ARBs)
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383217/full